Members |
targetComponentId |
furonculose de la peau et/ou du tissu sous-cutané |
furoncle |
Frusemide 10mg/mL injection solution 2mL ampule (product) |
Product containing precisely furosemide 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Sodium fusidate 500mg powder and solvent for infusion vial (product) |
Product containing precisely sodium fusidate 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
fœtus ou nouveau-né affecté par un accouchement et une extraction par le siège |
Fetal or neonatal effect of breech delivery and extraction |
fœtus ou nouveau-né affecté par un accouchement et une extraction par le siège |
Fetal or neonatal effect of breech delivery (disorder) |
Fetal or neonatal effect of maternal medical problem (disorder) |
Neonatal disorder due to disease in mother (disorder) |
Fetal or neonatal effect of maternal medical problem (disorder) |
Fetal disorder due to disease in mother (disorder) |
Fetal or neonatal effect of maternal infection |
Congenital infectious disease |
Fetal or neonatal effect of maternal infection |
Foetal damage from maternal infectious disorder |
Ganirelix 500micrograms/mL injection solution 0.5mL prefilled syringe (product) |
Ganirelix 500 microgram/mL solution for injection |
Diabetic gastroparesis associated with type 2 diabetes mellitus (disorder) |
Gastroparesis due to type 2 diabetes mellitus (disorder) |
Medical gases (product) |
Product manufactured as conventional release gas for inhalation (product) |
Medical gas (substance) |
produit pharmaceutique ou biologique |
gaz, émanations et vapeurs |
Gaseous substance |
Gentamicin 10mg/mL injection solution 2mL vial (product) |
Product containing precisely gentamicin (as gentamicin sulfate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Gentamicin 40mg/1mL injection ampule (product) |
Gentamicin (as gentamicin sulfate) 40 mg/mL solution for injection |
Day care/respite case management (procedure) |
Respite care case management (procedure) |
Day care/respite case management (procedure) |
Day care case management |
Glucagon 1mg(1iu) powder and solvent for injection solution (product) |
Product containing precisely glucagon hydrochloride 1 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Granisetron 1mg/1mL intravenous solution (product) |
Granisetron (as granisetron hydrochloride) 1 mg/mL solution for injection |
Granisetron 1mg/mL injection concentrate 3mL ampule (product) |
Granisetron (as granisetron hydrochloride) 1 mg/mL solution for injection |
greffe d'os et de moelle osseuse |
Blood and marrow transplantation (qualifier value) |
Haloperidol 10mg/mL injection solution 2mL ampule (product) |
Product containing precisely haloperidol 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Haloperidol 5mg/1mL injection (product) |
Product containing precisely haloperidol 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Congenital clicking hip |
Neonatal clicking hip |
Hemodiafiltration route (qualifier value) |
Hemodiafiltration technique (qualifier value) |
herpès associé au SIDA |
Infection caused by herpes simplex virus co-occurrent with human immunodeficiency virus infection |
Herpes gestationis with postnatal complication |
herpès gestationnel |
Accidentally struck by falling tree (event) |
Struck by falling tree |
Hit by object falling from aircraft, without accident to aircraft, occupant of spacecraft injured (event) |
Hit by object falling from aircraft (event) |
History of (present illness) (contextual qualifier) (situation) |
History of present illness section (record artifact) |
History of (present illness) (contextual qualifier) (situation) |
situation avec contexte explicite |
hormone, hormone synthétique de substitution ou hormone antagoniste |
Hormone |
hormone, hormone synthétique de substitution ou hormone antagoniste |
Drug or medicament (substance) |
Mood, function (observable entity) |
Mood |
Mood, function (observable entity) |
Emotion function (observable entity) |
Hydroxocobalamin |
Hydroxocobalamin (substance) |
Hydroxocobalamin |
Aquacobalamin (substance) |
hygroma |
Subdural hygroma |
hygroma |
Cystic hygroma (disorder) |
Bladder muscle dysfunction - overactive |
Overactive bladder |
Bladder muscle dysfunction - overactive |
Detrusor overactivity |
Hypersplenism associated with AIDS |
Splenomegaly co-occurrent with human immunodeficiency virus infection |
Hypomobility |
Limitation of joint movement |
Hypomobility |
Impaired mobility |
Unilateral condylar hypoplasia of mandible |
Hypoplasia of left condyloid process of mandible (disorder) |
Unilateral condylar hypoplasia of mandible |
Hypoplasia of right condyloid process of mandible (disorder) |
Hypothyroidism due to drugs |
Hypothyroidism caused by drug (disorder) |
Hypovolemia associated with AIDS |
Hypovolemia (finding) |
Hypoxia, asphyxia AND/OR other respiratory condition of fetus AND/OR newborn |
Birth asphyxia (disorder) |
Hypoxia, asphyxia AND/OR other respiratory condition of fetus AND/OR newborn |
Intrauterine asphyxia |
Hypoxia, asphyxia AND/OR other respiratory condition of fetus AND/OR newborn |
Perinatal asphyxia |
Hypoxia, asphyxia AND/OR other respiratory condition of fetus AND/OR newborn |
Respiratory condition of fetus OR newborn |
Hypoxia, asphyxia AND/OR other respiratory condition of fetus AND/OR newborn |
Fetal hypoxia |
hématome de la jambe |
Haematoma of lower leg |
hématome de la jambe |
Haematoma of lower limb |
Recurrent or persistent hematuria |
hématurie persistante |
Recurrent or persistent hematuria |
hématurie récidivante |
Recurrent or persistent hematuria, minor glomerular abnormality |
Recurrent hematuria co-occurrent and due to minor glomerular abnormality (disorder) |
Recurrent or persistent hematuria, minor glomerular abnormality |
Persistent hematuria co-occurrent and due to minor glomerular abnormality (disorder) |
Recurrent or persistent hematuria, diffuse crescentic glomerulonephritis |
Recurrent hematuria co-occurrent and due to diffuse crescentic glomerulonephritis (disorder) |
Recurrent or persistent hematuria, diffuse crescentic glomerulonephritis |
Persistent hematuria co-occurrent and due to diffuse crescentic glomerulonephritis (disorder) |
Recurrent or persistent hematuria, diffuse membranous glomerulonephritis |
Persistent hematuria co-occurrent and due to diffuse membranous glomerulonephritis (disorder) |
Recurrent or persistent hematuria, diffuse membranous glomerulonephritis |
Recurrent hematuria co-occurrent and due to diffuse membranous glomerulonephritis (disorder) |
Recurrent or persistent hematuria, diffuse mesangiocapillary glomerulonephritis |
Persistent hematuria co-occurrent and due to diffuse mesangiocapillary glomerulonephritis (disorder) |
Recurrent or persistent hematuria, diffuse mesangiocapillary glomerulonephritis |
Recurrent hematuria co-occurrent and due to diffuse mesangiocapillary glomerulonephritis (disorder) |
Recurrent or persistent hematuria, diffuse endocapillary proliferative glomerulonephritis |
Persistent hematuria co-occurrent and due to diffuse endocapillary proliferative glomerulonephritis (disorder) |
Recurrent or persistent hematuria, diffuse endocapillary proliferative glomerulonephritis |
Recurrent hematuria co-occurrent and due to diffuse endocapillary proliferative glomerulonephritis (disorder) |
Recurrent or persistent hematuria, diffuse mesangial proliferative glomerulonephritis |
Recurrent hematuria co-occurrent and due to diffuse mesangial proliferative glomerulonephritis (disorder) |
Recurrent or persistent hematuria, diffuse mesangial proliferative glomerulonephritis |
Persistent hematuria co-occurrent and due to diffuse mesangial proliferative glomerulonephritis (disorder) |
Recurrent or persistent hematuria, focal and segmental glomerular lesions |
Persistent hematuria co-occurrent and due to focal and segmental glomerular lesions (disorder) |
Recurrent or persistent hematuria, focal and segmental glomerular lesions |
Recurrent hematuria co-occurrent and due to focal and segmental glomerular lesions (disorder) |
Recurrent or persistent hematuria, dense deposit disease |
hématurie récidivante |
Recurrent or persistent hematuria, dense deposit disease |
hématurie persistante |
hémorragie du début de la grossesse |
Hemorrhagic complication of pregnancy |
hémorragie du début de la grossesse |
First trimester bleeding (disorder) |
Internal hemorrhoids, simple |
hémorroïdes internes de grade I (trouble) |
Heparin calcium 25,000iu/mL injection solution 0.2mL ampule (product) |
Product containing precisely heparin calcium 25000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Heparin calcium 25,000iu/mL injection solution 0.2mL prefilled syringe (product) |
Product containing precisely heparin calcium 25000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Heparin calcium 25,000iu/mL injection solution 0.5mL prefilled syringe (product) |
Product containing precisely heparin calcium 25000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Heparin sodium 1000iu/mL infusion solution 10mL ampule (product) |
Product containing precisely heparin sodium 1000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Heparin sodium 1000iu/mL infusion solution 20mL ampule (product) |
Product containing precisely heparin sodium 1000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Heparin sodium 1000iu/mL injection solution 1mL ampule (product) |
Product containing precisely heparin sodium 1000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Heparin sodium 1000iu/mL infusion solution 5mL ampule (product) |
Product containing precisely heparin sodium 1000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Heparin sodium 25,000iu/5mL injection vial (product) |
Heparin sodium 5000 unit/mL solution for injection |
Heparin sodium 25,000iu/mL injection solution 0.2mL ampule (product) |
Product containing precisely heparin sodium 25000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Heparin sodium 25,000iu/mL injection solution 1mL ampule (product) |
Product containing precisely heparin sodium 25000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Heparin sodium 25,000iu/mL injection solution 5mL vial (product) |
Product containing precisely heparin sodium 25000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Heparin sodium 5000iu/5mL injection vial (product) |
Product containing precisely heparin sodium 1000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Heparin sodium 5000iu/mL injection solution 1mL ampule (product) |
Heparin sodium 5000 unit/mL solution for injection |
Heparin sodium 5000iu/mL injection solution 5mL ampule (product) |
Heparin sodium 5000 unit/mL solution for injection |
imagerie par résonance magnétique des vaisseaux cérébraux |
Magnetic resonance angiography of cerebrovascular system |
imagerie par résonance magnétique des vaisseaux cérébraux |
Magnetic resonance angiography of intracranial vessels |
Implantation of baffle, atrial or interatrial |
Insertion of atrial baffle |
Implantation of baffle, atrial or interatrial |
creation d'un tunnel interauriculaire |
implantation de tissu mou |
Surgical procedure on soft tissue (procedure) |
implantation de tissu mou |
Implantation procedure (procedure) |
incendie à bord d'un avion en vol, parachutiste blessé |
Fire on powered aircraft whilst in flight |
incendie à bord d'un avion pendant l'atterrissage, passager d'un vaisseau spatial blessé |
Fire on powered aircraft while landing (event) |
Fire on aircraft while in transit, spacecraft occupant injured (event) |
Fire on powered aircraft whilst in flight |
Congenital postural curvature of spine |
Congenital kyphosis |